LP-093 Role of leukocyte immunoglobulin-like receptor a3 (LILRA3) in the pathogenesis of lupus-like disease
Main Authors: | Chen Chen, Jianping Guo, Yundi Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-07-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
LP-087 LILRA3 plays a protective role in MAS-like disease
by: Chen Chen, et al.
Published: (2023-07-01) -
Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome
by: Evangelia Argyriou, et al.
Published: (2021-02-01) -
Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
by: Hongyan An, et al.
Published: (2016-01-01) -
Human leukocyte immunoglobulin-like receptors in health and disease
by: Silvia Redondo-García, et al.
Published: (2023-11-01) -
LP-190 Successful treatment of rituximab and bortezomib in refractory systemic lupus erythematosus: a case report
by: Chen Chen, et al.
Published: (2023-07-01)